Dr. Martens Plc (3U2) Stock Statistics & Valuation Metrics
Total Valuation
Dr. Martens Plc has a market cap or net worth of EUR 752.59M. The enterprise value is EUR 819.77M.
- Market Cap
- EUR 752.59M
- Enterprise Value
- EUR 819.77M
Share Statistics
Dr. Martens Plc has 968,121,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 968,121,300
- Owned by Insiders
- 0.20%
- Owned by Institutions
- 13.39%
Financial Efficiency
Dr. Martens Plc’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 7.00%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 7.00%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 321.79K
- Profits Per Employee
- 10.01K
- Employee Count
- 2,377
- Asset Turnover
- 0.87
- Inventory Turnover
- 1.61
Valuation Ratios
The current PE Ratio of Dr. Martens Plc is 26.35. Dr. Martens Plc’s PEG ratio is 0.05.
- PE Ratio
- 26.35
- PS Ratio
- 0.82
- PB Ratio
- 1.74
- Price to FCF
- 5.40
- Price to Operating Cash Flow
- 5.00
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Dr. Martens Plc had revenue of 764.90M and earned 23.80M in profits. Earnings per share was 0.02.
- Revenue
- 764.90M
- Gross Profit
- 506.00M
- Operating Income
- 73.40M
- Pretax Income
- 32.70M
- Net Income
- 23.80M
- EBITDA
- 142.10M
- Earnings Per Share (EPS)
- 0.02
Cash Flow
In the last 12 months, operating cash flow was 125.50M and capital expenditures -9.20M, giving a free cash flow of 116.30M billion.
- Operating Cash Flow
- 125.50M
- Free Cash Flow
- 116.30M
- Free Cash Flow per Share
- 0.12
Dividends & Yields
Dr. Martens Plc pays an annual dividend of ―, resulting in a dividend yield of 3.84%
- Dividend Per Share
- ―
- Dividend Yield
- 3.84%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 18.52%
- Earnings Yield
- 3.79%
Stock Price Statistics
- Beta
- 0.95
- 52-Week Price Change
- -25.25%
- 50-Day Moving Average
- 0.79
- 200-Day Moving Average
- 0.77
- Relative Strength Index (RSI)
- 46.58
- Average Volume (3m)
- 1,443
Important Dates
Dr. Martens Plc upcoming earnings date is Nov 19, 2026, TBA (Not Confirmed).
- Last Earnings Date
- May 19, 2026
- Next Earnings Date
- Nov 19, 2026
- Ex-Dividend Date
- ―
Financial Position
Dr. Martens Plc as a current ratio of 2.61, with Debt / Equity ratio of 108.85%
- Current Ratio
- 2.61
- Quick Ratio
- 1.60
- Debt to Market Cap
- 0.41
- Net Debt to EBITDA
- 1.50
- Interest Coverage Ratio
- 2.65
Taxes
In the past 12 months, Dr. Martens Plc has paid 8.90M in taxes.
- Income Tax
- 8.90M
- Effective Tax Rate
- 0.27
Enterprise Valuation
Dr. Martens Plc EV to EBITDA ratio is 5.80, with an EV/FCF ratio of 7.23.
- EV to Sales
- 1.10
- EV to EBITDA
- 5.80
- EV to Free Cash Flow
- 7.23
- EV to Operating Cash Flow
- 6.70
Balance Sheet
Dr. Martens Plc has EUR 180.30M in cash and marketable securities with EUR 393.50M in debt, giving a net cash position of -EUR 213.20M billion.
- Cash & Marketable Securities
- EUR 180.30M
- Total Debt
- EUR 393.50M
- Net Cash
- -EUR 213.20M
- Net Cash Per Share
- -EUR 0.22
- Tangible Book Value Per Share
- EUR 0.10
Margins
Gross margin is 57.17%, with operating margin of 10.01%, and net profit margin of 3.11%.
- Gross Margin
- 57.17%
- Operating Margin
- 10.01%
- Pretax Margin
- 4.28%
- Net Profit Margin
- 3.11%
- EBITDA Margin
- 18.97%
- EBIT Margin
- 9.99%
Analyst Forecast
The average price target for Dr. Martens Plc is EUR 1.08, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 1.08
- Price Target Upside
- 42.86% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 4
- Revenue Growth Forecast
- -5.76%
- EPS Growth Forecast
- 360.66%
Scores
- Smart Score
- 2
- AI Score
- ―
